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Abstract
Background: Cell-free	microRNAs	 (miRs)	have	emerged	as	early	and	sensitive	bio-
markers	for	tissue	injury	and	function.	This	study	aimed	to	investigate	whether	the	
release	of	hepatocyte-derived	microRNAs	(HDmiRs)	and	cholangiocyte-derived	miRs	
(CDmiRs)	 correlates	with	hepato-cholangiocellular	 injury	 and	 function	during	oxy-
genated,	normothermic	machine	perfusion	(NMP)	of	human	liver	grafts.
Methods: Donor	livers	(n	=	12),	declined	for	transplantation,	were	subjected	to	oxy-
genated	NMP	(6	hours)	after	a	period	of	static	cold	storage	(median	544	minutes	(IQR	
421-674)).	Perfusate	and	bile	samples	were	analyzed	by	qRT-PCR	for	HDmiR-122	and	
CDmiR-222.	 Spearman	 correlations	were	 performed	 between	miR	 levels	 and	 cur-
rently	available	indicators	and	classic	markers.
Results: Both	HDmiR-122	and	CDmiR-222	levels	in	perfusate	at	30	minutes	of	NMP	
strongly	correlated	with	hepatocyte	injury	(peak	perfusate	AST)	and	cholangiocyte	in-
jury	(peak	biliary	LDH).	In	bile,	only	CDmiR-222	correlated	with	these	injury	markers.	
For	hepato-cholangiocellular	 function,	both	miRs	 in	perfusate	correlated	with	total	
bilirubin,	while	HDmiR-122	(in	perfusate)	and	CDmiR-222	(in	bile)	correlated	with	bi-
carbonate	secretion.	Both	the	relative	ratio	of	HDmiR-122/CDmiR-222	and	AST	 in	
perfusate	at	30	minutes	significantly	correlated	with	cumulative	bile	production,	but	
only	the	relative	ratio	was	predictive	of	histopathological	injury	after	6	hours	NMP.
Conclusion: Early	levels	of	HDmiR-122	and	CDmiR-222,	in	perfusate	and/or	bile,	are	
predictive	of	excretory	functions	and	hepato-cholangiocellular	 injury	after	6	hours	
NMP.	These	miRs	may	represent	new	biomarkers	for	graft	viability	and	function	dur-
ing machine perfusion.
K E Y W O R D S
biomarker,	cholangiocyte-derived	microRNA,	hepatocyte-derived	microRNA,	miR-122,	miR-
222,	transplantation
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1  | INTRODUC TION
To	address	the	global	shortage	of	donor	livers,	the	use	of	“extended	
criteria”	donor	livers,	which	include	steatotic,	elderly,	and	donation	
after	 circulatory	death	 (DCD)	 livers,	 has	 substantially	 increased.1,2 
Organs	from	these	donors	typically	are	more	susceptible	to	ischemic	
damage,	resulting	in	an	increased	incidence	of	primary	non-function,	
early	allograft	dysfunction	(EAD),	and	biliary	complications	such	as	
non-anastomotic	strictures	(NAS).3-5
Normothermic	machine	perfusion	(NMP)	is	a	technique	whereby	
donor	livers	are	perfused	ex	situ.	At	37°C,	NMP	renders	the	organ	
metabolically	 active,	 offering	 a	window	 for	 assessing	 the	 viability	
of	the	graft.	Several	research	groups	have	proposed	putative	mark-
ers	of	organ	viability	 in	 this	 context,	 but	 their	 utility	 in	predicting	
outcome thus far is limited.6-8	The	 lack	of	 reliable,	objective	mea-
surements	to	determine	organ	quality	prior	to	transplantation	limits	
clinicians	in	predicting	graft	performance	following	transplantation	
and	possibly	improving	graft	function	during	machine	perfusion.
In	 the	 field	 of	 biomarker	 discovery,	 small	 non-coding	RNAs,	 in	
particular	microRNAs	(miRs),	have	emerged	as	sensitive,	specific	and	
stable	markers	for	cell	function,	cell	stress	and	cell	injury.	MiRs	are	
important	regulators	of	post-transcriptional	gene	expression	and	as	
such	control	many	cellular	processes.	They	can	down-regulate	cer-
tain	processes	by	preventing	translation	of	messenger	RNA	(mRNA)	
into	 functional	 proteins	 whereas	 others	 upregulate	 other	 cellular	
functions.9	 Several	 studies	 have	 recently	 investigated	 the	 release	
of	miRs	 in	 relation	 to	 cellular	 injury	 resulting	 from	 liver	 transplan-
tation.10-13	It	was	shown	that	not	only	levels	of	released	miRs	differ	
between	damaged	and	normal	functioning	hepatocytes	and	cholan-
giocytes	but	also	that,	during	impaired	excretory	function	and	injury	
of	 hepatocytes,	 the	 liver	 shows	 polarized	 release	 of	 extracellular	
hepatocyte-derived	miRs	(HDmiRs)	and	cholangiocyte-derived	miRs	
(CDmiRs)	into	both	bile	and	serum,	suggesting	active	rather	than	pas-
sive	underlying	release	mechanisms.14
The	aim	of	the	current	study	was	to	assess	whether	miRs	in	the	
perfusate	 and	 bile	 of	 normothermically	 perfused	 liver	 grafts	 cor-
relate	with,	and	are	predictive	of,	hepatocellular	and	cholangiocel-
lular	 injury	 and	 liver	 function	 as	 measured	 by	 currently	 available	
indicators	and	classic	markers.	Furthermore,	 the	 levels	of	miRs	on	
different	time	points	during	NMP	were	investigated	and	correlated	
with	the	aforementioned	markers.
2  | MATERIAL S AND METHODS
2.1 | Donor livers
Between	August	2012	and	August	2014,	twelve	consecutive	human	
donor	livers,	declined	for	transplantation,	were	included	in	this	study	
after	informed	consent	had	been	obtained.	Following	a	period	of	static	
cold	storage	(SCS)	(544	minutes	(421-674)),	livers	underwent	6	hours	
of	NMP	for	viability	assessment.	This	cohort	has	been	previously	de-
scribed	in	the	study	by	Westerkamp	et	al	2016	(“SCS-only”	group).15
The	 study	protocol	was	 approved	by	 the	medical	 ethical	 com-
mittee	of	the	University	Medical	Center	Groningen	(UMCG)	(METC	
2012.068)	and	the	Dutch	Transplantation	Foundation	(NTS).
2.2 | Machine perfusion
Upon	 arrival	 at	 the	 UMCG,	 NMP	 was	 performed	 using	 the	 Liver	
Assist	(Organ	Assist,	Groningen,	the	Netherlands)	with	a	perfusion	
solution	based	on	packed	 red	blood	 cells	 and	 fresh	 frozen	plasma	
as	described	previously.15	Bile	and	perfusion	fluid	samples	were	ob-
tained	at	baseline	prior	 to	 connecting	 the	 liver	 and	at	30	minutes	
intervals,	 and	 essentially	 deprived	 of	 cells	 by	 centrifugation	 for	
5	minutes	at	2700	rpm.	Supernatants	were	subsequently	stored	at	
−80°C	until	further	use.
2.3 | Assessment of hepatobiliary 
function and injury
Lactate,	 glucose,	 bicarbonate,	 and	 total	 bilirubin	 were	 measured	
using	 an	 ABL800	 FLEX	 analyzer	 (Radiometer,	 Brønhøj,	 Denmark).	
Aspartate	aminotransferase	(AST)	and	lactate	dehydrogenase	(LDH)	
were	measured	using	routine	biochemical	methods.	Cumulative	bile	
production,	measured	gravimetrically,	was	expressed	as	mL	bile/kg	
liver.
2.4 | RNA isolation
Fifty	µl	of	essentially	 cell-free	bile	or	cell-free	perfusion	 fluid	was	
supplemented	with	150	µL	PBS,	and	total	RNA	was	extracted	using	
the	Qiagen	miRNeasy	kit	(Qiagen,	Venlo,	the	Netherlands)	essentially	
as	described	previously.12,14	Samples	were	spiked	with	200	amol	of	
artificial Caenorhabditis elegans	miR-39	 (Cel-miR-39,	Sigma	Aldrich,	
Zwijndrecht,	the	Netherlands)	during	the	lysis	procedure	to	monitor	
loss	during	workup.	RNA	was	eluted	using	50	µL	of	nuclease-free	
water	and	stored	at	−80°C	until	further	use.
2.5 | Reverse transcription and real-time 
polymerase chain reaction (qRT-PCR)
Complement	 DNA	 (cDNA)	 synthesis	 was	 performed	 using	 the	
Taqman	microRNA	Reverse	Transcription	Kit	 (Applied	Biosystems,	
Carlsbad,	CA,	USA)	 as	 suggested	by	 the	manufacturer	with	minor	
modifications	 as	 described	 previously.16	 To	 eliminate	 qRT-PCR	 in-
hibition	by	heparin,	 the	RT	reactions	were	co-incubated	with	6	 IU	
heparinase	(New	England	Biolabs).17	One	hundred	amol	of	synthetic	
Cel-miR-54	was	 added	 to	monitor	 the	 presence	 of	 PCR	 inhibiting	
components	that	co-eluted	with	total	RNA,	and/or	incomplete	hepa-
rin	degradation.	cDNA	samples	were	diluted	to	100	μL	with	nuclease-
free	water	and	stored	at	−20°C	until	further	use.	PCR	reactions	were	
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performed	in	duplicate	essentially	as	described	by	the	manufacturer	
with	the	following	modifications:	Six	μL	Taqman	2×	Universal	PCR	
Master	Mix	was	mixed	with	0.5	μL	microRNA-specific	PCR	primer	
(Applied	Biosystems),	0.5	μL	nuclease-free	water,	and	5.0	μL	of	the	
diluted	cDNA.	The	mature	sequences	of	the	miRNAs	analyzed,	both	
endogenous	and	synthetic,	are	summarized	in	Table	1.
2.6 | Histological analysis
Liver	biopsies	were	collected	before	and	after	6	hours	of	NMP	and	
fixed	in	formalin.	Liver	parenchymal	injury	(LPI)	was	determined	on	
paraffin-embedded	and	H&E	stained	sections	by	two	independent	
investigators	using	the	semi-quantitative	Suzuki	injury	score	as	de-
scribed	previously.18
2.7 | Statistical analysis
Levels	 of	 endogenous	 miRs	 in	 perfusate	 and	 bile,	 represented	 as	
relative	 values	 (2-Cq),	 were	 normalized	 using	 the	 relative	 values	 of	
the	 spiked-in	 synthetic	 Cel-miR-39	 as	 described	 by	 Vandesompele	
et	al	with	the	highest	relative	value	set	to	1.19	Continuous	variables	
were	presented	as	median	with	 interquartile	 rage	 (IQR).	 In	order	 to	
determine	 the	 predictive	 value	 of	 both	miRs,	 relative	miR	 levels	 in	
perfusate	at	30	minutes	and	in	bile	at	2	hours	were	correlated	with	
hepato-cholangiocellular	parameters	using	the	Spearman	correlations	
test.	Suzuki	scores	for	LPI	before	and	after	NMP	were	compared	using	
a paired t	test.	The	level	of	significance	was	set	at	P	<	.05.	All	statisti-
cal	 analyses	were	performed	using	SPSS	 software	 version	22.0	 for	
Windows	(SPSS,	Inc)	and	GraphPad	Prism	5.0	(GraphPad	Software).
3  | RESULTS
3.1 | Hepato-cholangiocellular injury and function 
parameters during NMP
An	overview	of	donor	characteristics	has	previously	been	published	
by	Westerkamp	et	al	(“SCS-only”	group)	and	is	provided	in	Table	2.15 
Supplemental	figure	S1	shows	the	levels	of	hepatocellular	injury	and	
function	parameters	during	6	hours	of	NMP.	AST	in	perfusate	and	
LDH	 in	 bile	 reflect	 hepatocyte	 and	 cholangiocyte	 injury,	 respec-
tively.	 Lactate	 in	 perfusate,	 bilirubin	 in	 bile,	 and	 (cumulative)	 bile	
production	 reflect	 hepatocyte	 function	 during	 NMP.	 Bicarbonate	
in	 bile	 and	 the	 bile	 glucose/perfusate	 glucose	 ratio	 are	 indicators	
of	 cholangiocyte	 secretory	 function	 and	 cholangiocyte	 resorptive	
function,	respectively.20
TA B L E  1  Mature	microRNA	sequences	and	assays
microRNA Mature sequence Assay ID
hsa-miR-122 UGGAGUGUGACAAUGGUGUUUG 002245
hsa-miR-222 AGCUACAUCUGGCUACUGGGU 002276
cel-miR-39 UCACCGGGUGUAAAUCAGCUUG 000200
cel-miR-54 UACCCGUAAUCUUCAUAAUCCGAG 001361
TA B L E  2  Donor	characteristics
 n = 12
Age	(y) 61	(52-64)
Gender
Male 8	(67%)
Female 4	(33%)
Length	(m) 1.77	(1.67-1.80)
Weight	(kg) 88	(76-100)
Body	mass	index	(kg/m2) 27.3	(24.5-36.0)
Type	of	donor	liver
DCD 9	(75%)
DBD 3	(25%)
Cause of death
Cardiovascular 2	(16%)
Post-anoxia 5	(42%)
Trauma 5	(42%)
Reasons	livers	were	declined	for	transplantation
DCD	+	age	>60	y 5	(42%)
DCD	+	high	BMI 5	(42%)
DCD	+	high	transaminases 2	(16%)
Type	of	preservation	solution
UW	solution 9	(75%)
HTK	solution 3	(25%)
Time	between	withdrawal	of	life	support	
treatment	and	circulatory	arrest	(min)a
20	(4-46)
Time	between	circulatory	arrest	and	cold	flush	
in	situ	(min)a
18	(12-22)
Cold	ischemia	time	(min)b 544	(421-674)
Reasons	livers	were	declined	for	transplantation
DCD	+	age	>60	y 5	(42%)
DCD	+	high	BMI 5	(42%)
DCD	+	high	transaminases 2	(16%)
Histological	findings	before	start	NMP
Suzuki	injury	score 2	(1-3)
Histological	findings	after	6	h	of	NMP
Suzuki	injury	score 3	(2-4.25)
Donor	risk	index 2.79	(2.24-3.21)
Weight	of	liver	(kg) 2.11	(1.81-2.30)
Note: Data	represented	as	median	(interquartile	ranges)	for	continuous	
variables	or	as	numbers	(percentages)	for	categorical	variables.
Abbreviations:	BMI,	body	mass	index;	DCD,	donation	after	circulatory	
death;	DBD,	donation	after	brain	death;	HTK,	histidine-tryptophan-
ketoglutarate;	SCS,	static	cold	storage;	UW,	University	of	Wisconsin.
aThe	total	of	both	periods	can	be	defined	as	the	total	donor	warm	
ischemia	time	during	DCD	donation.	
bPeriod	between	cold	flush	out	of	the	liver	in	the	donor	and	start	of	
machine perfusion. 
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3.2 | Hepatocyte- and cholangiocyte-derived miRs 
in perfusate and bile during NMP
Figure	1A	and	1B	showed	the	relative	values	of	HDmiR-122	in	perfu-
sate	and	in	bile	during	NMP,	and	Figure	1C	and	1D	showed	the	relative	
values	of	CDmiR-222	in	the	same	fluids.	Overall,	relative	HDmiR-122	
values	were	higher	than	relative	CDmiR-222	values.	Figure	1E	and	
1F	 illustrated	 the	 relative	 ratios	between	HDmiR-122	and	CDmiR-
222	in	the	respective	fluids.	Both	HDmiR-122	and	CDmiR-222	levels	
in	 perfusate	 initially	 increased	 during	 the	 first	 30	minutes	 of	 per-
fusion,	and	the	median	values	showed	a	slight,	but	not	significant,	
decrease	when	 relative	values	were	determined	 in	perfusate	sam-
ples	taken	after	6	hours	NMP	(Figure	1A	and	1).	The	HDmiR-122/
CDmiR-222	 ratio	 in	 perfusate	 decreased	 over	 time	 in	 most	 livers	
after	an	initial	peak	at	30	minutes	of	perfusion	(Figure	1E).	Relative	
levels	of	HDmiR-122	in	bile	showed	a	different	trend	with	a	median	
continuous	increase	during	perfusion	(Figure	1B).	The	mean	relative	
value	of	CDmiR-222	in	bile	however,	although	also	not	significantly,	
decreased	during	the	6	hours	of	perfusion	(Figure	1D).	The	HDmiR-
122/CDmiR-222	ratio	in	bile	therefore	increased	in	most	livers,	indi-
cating	that	there	was	relatively	more	HDmiR-122	than	CDmiR-222	in	
bile	after	5.5	hours	of	perfusion	(P	<	.001;	Figure	1F).
3.3 | miR levels and microscopic assessment of liver 
parenchymal injury
Often	livers,	declined	for	transplantation	on	subjective	assessment	
by	 the	 transplant	 surgeon,	 were	 shown	 to	 display	 minimal	 mor-
phological	changes	after	histological	examination.21	We	set	out	 to	
evaluate	the	histological	observations	described	earlier	22 and cor-
relate	 these	 data	with	 relative	miRNA	 levels	 and	 the	HDmiR122/
CDmiR222	ratio.	Suzuki	injury	scores	at	the	start	and	end	of	NMP	
were	compared	with	our	early	predictors	HDmiR-122,	CDmiR-222,	
and	their	ratio	in	perfusate	at	30	minutes.	Median	(IQR)	scores	were	
2	(1-3)	before	NMP	and	3	(2-4.5)	after	6	hours	NMP	and	were	signifi-
cantly	different	(P	=	.001).	This	suggests	progression	of	injury	during	
NMP.	A	significant	positive	correlation	with	the	Suzuki	injury	score	
and	miRs	 at	 the	 start	 of	NMP	was	 observed	 (HDmiR-122	 r	 =	 .79,	
P	<	.05;	CDmiR-222	r	=	.68,	P	<	.01;	Figure	2A).	The	relative	CDmiR-
222	 levels,	 but	 not	 the	 relative	 HDmiR-122	 levels,	 at	 30	minutes	
NMP	were	also	significantly	associated	with	the	Suzuki	injury	score	
after	6	hours	of	NMP	(P	<	 .05)	 (data	not	shown).	The	HDmiR122/
CDmiR222	ratio	in	perfusate	after	30	minutes	showed	a	good	cor-
relation	with	the	Suzuki	injury	score	after	6	hours	NMP	(Figure	2B).
3.4 | Early miR release into perfusate is predictive of 
late hepato-cholangiocellular parameters
Peak	HDmiR-122	levels	precede	peak	serum	AST	levels	 in	predict-
ing	the	onset	of	hepatic	injury	from	acute	rejection.16 To investigate 
this	observation	during	NMP,	the	relative	values	of	HDmiR-122	and	
CDmiR-222	in	perfusate	early	during	machine	perfusion	(30	minutes)	
were	correlated	to	peak	AST	levels	within	6	hours	of	NMP.	A	positive	
correlation	was	observed	for	both	HDmiR-122	and	CDmiR-222	with	
peak	AST	levels	during	the	6	hours	reperfusion	period	(HDmiR-122	
r	=	 .90,	P	<	 .001;	CDmiR-222	r	=	 .78,	P	<	 .01;	Figure	3A).	A	similar	
observation	was	made	 for	peak	LDH	 in	bile,	which	also	 showed	a	
positive	and	significant	correlation	with	HDmiR-122	(r	=	.76,	P	<	.01)	
and	CDmiR-222	(r	=	.63,	P	=	.04;	Figure	3B).	No	significant	correla-
tion	was	observed	between	early	miR	levels	and	lactate	at	6	hours	
of	NMP	and	cumulative	bile	production	(HDmiR-122	r	=	.45,	P	=	.15	
and r	=	−0.39,	P	=	.21,	respectively;	CDmiR-222	r	=	.30,	P	=	.34	and	
r	=	−.50,	P	=	.10,	respectively)	(data	not	shown).	There	was,	however,	
a	 significant	 negative	 correlation	between	early	miR	 levels	 in	 per-
fusate	and	bilirubin	levels	in	bile	after	6	hours	of	NMP	(HDmiR-122	
r	=	−.72,	P	=	.02;	CDmiR-222	r	=	−.78,	P	=	.01;	Figure	3C).	Bicarbonate	
concentration	in	bile	at	6	hours,	an	indicator	of	cholangiocyte	func-
tion,	correlated	significantly	and	negatively	with	early	HDmiR-122	
levels	(r	=	−.65,	P	=	.02)	in	perfusate	and	nearly	reached	significance	
with	early	CDmiR-222	(r	=	−.54,	P	=	.07;	Figure	3D).	The	bile	glucose/
perfusate	 glucose	 ratio	 did	 not	 show	 a	 correlation	with	 early	miR	
levels	in	perfusate	(HDmiR-122	r	=	.23,	P	=	.55;	CDmiR-222	r	=	.20,	
P	=	.61;	data	not	shown).
3.5 | CDmiR-222 release into bile is predictive of 
later hepato-cholangiocellular parameters, except for 
hepatocellular and cholangiocyte resorptive functions
The	 relative	 values	 of	 CDmiR-222	 in	 bile	 at	 2	 hours	 NMP	 corre-
lated	very	strongly	with	peak	AST	in	perfusate	and	peak	LDH	in	bile	
(r	=	 .88,	P < .001 and r	=	 .81,	P	=	 .003,	respectively;	Figure	4A-B).	
HDmiR-122	in	bile	correlated	less	strongly,	and	nearly	significantly,	
with	peak	AST	but	not	with	peak	LDH	in	bile	 (r	=	 .61,	P	=	 .05	and	
r	=	.46,	P	=	.16	respectively).	None	of	the	hepatocellular	function	pa-
rameters,	lactate	in	perfusate,	total	bilirubin	in	bile,	or	total	bile	pro-
duction	correlated	with	either	HDmiR-122	(r	=	.21,	P	=	.54;	r	=	−.56,	
P	=	.09	and	r	=	.03,	P	=	.96,	respectively)	or	CDmiR-222	in	bile	(r	=	.47,	
P	=	.14;	r	=	−.50,	P	=	.14	and	r	=	−.15,	P	=	.20,	respectively)	(data	not	
shown).	Bicarbonate	in	bile,	however,	did	show	a	strong	and	negative	
correlation	with	CDmiR-222	 in	bile	 (r	=	−.89,	P	<	 .001;	Figure	4C),	
while	the	glucose	bile/perfusate	ratio,	which	is	higher	in	livers	with	
poor	cholangiocyte	resorptive	function,	correlated	strongly	and	pos-
itively	with	both	HDmiR-122	(r	=	−.70,	P	=	.04)	and	CDmiR-222	in	bile	
(r	=	.72,	P	=	.03;	Figure	4D).
3.6 | The relative HDmiR-122/CDmiR-222 ratio in 
perfusate correlates with cumulative bile production
Cumulative	bile	production	during	NMP	has	been	considered	a	good	
parameter	 of	 liver	 function	 in	 non-transplanted	 research	 livers.15 
Therefore,	we	correlated	the	previously	mentioned	clinical	markers	
in	perfusate	and	bile,	as	well	as	the	HDmiR-122/CDmiR-222	ratio,	to	
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F I G U R E  1  Dynamics	of	HDmiR-122	and	CDmiR-222	levels	in	perfusate	and	bile	during	NMP.	Relative	values	of	HDmiR-122	(A,	B),	
CDmiR-222	(C,	D),	and	the	HDmiR-122/CDmiR-222	ratio	(E,	F)	in	perfusate	(A,	C,	E),	and	bile	(B,	D,	F).	In	perfusate	median	values	of	both	
miRs	peaked	after	2	h	of	NMP	and	slowly	declined	thereafter	(A,	C).	In	bile,	median	relative	values	of	HDmiR-112	significantly	increase	
between	0.5	and	2	h	(B).	The	miR	ratio	in	bile	significantly	increase	over	time	during	NMP.	MiR	levels	are	represented	as	relative	values	(2−
Cq).	Solid	lines	and	bars:	Median	±	IQR,	dotted	lines:	relative	miR	value	profiles	for	each	individual	sample.	**P	<	.01,	***P < .001
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the	cumulative	bile	production	after	6	hours	of	perfusion	(Figure	5).	
Early	AST	levels	negatively	correlated	with	cumulative	bile	produc-
tion	(r	=	−.76,	P	=	.01)	as	is	shown	in	Figure	5A.	This	was,	however,	
not	the	case	for	LDH	(r	=	−.58,	P	=	.10),	 lactate	(r	=	−.25,	P	=	.46),	
total	bilirubin	in	bile	(r	=	.32,	P	=	.41),	bicarbonate	in	bile	(r	=	−.21,	
P	=	.51),	or	HDmiR-122	or	CDmiR-222	levels	in	perfusate	(r	=	−.39,	
P	 =	 .21;	 r	 =	 −.5,	P	 =	 .10,	 respectively)	 and	bile	 (r	 =	 −.08,	P	 =	 .99;	
r =	−.42,	P	=	.20,	respectively)	(data	not	shown).	Interestingly,	cumu-
lative	bile	production	at	30	minutes	was	not	predictive	for	cumula-
tive	bile	production	5.5	hours	 later	 (r	=	 .28,	P	=	 .38)	 (not	 shown).	
Cumulative	 bile	 production	 did,	 however,	 correlate	 significantly	
with	the	ratio	of	the	relative	HDmiR-122/CDmiR-222	values	in	per-
fusate	after	30	minutes	(r	=	0.67,	P	=	.01;	Figure	5B).
4  | DISCUSSION
The	aim	of	this	study	was	to	assess	whether	hepatocyte-	and	chol-
angiocyte-derived	miR	 levels	 in	perfusate	and	bile	were	predictive	
of	function	and	injury	after	6	hours	of	ex	situ	NMP	of	human	liver	
grafts.	 This	 is	 the	 first	 study	 to	 report	 on	miRs	 at	 different	 time	
points	during	NMP	of	human	donor	livers.
Overall,	 the	 current	 study	 showed	 that	 poor	 quality	 liver	 grafts	
with	 high	 hepato-cholangiocellular	 injury	 (defined	 as	 high	 AST	 and	
LDH	peaks	 in	perfusate	and	bile,	respectively)	and	 low	hepato-chol-
angiocellular	function	(reflected	by	high	lactate	levels	in	perfusate,	low	
levels	of	bilirubin	in	bile,	 low	total	bile	production	and	a	low	glucose	
bile/perfusate	ratio)	had	higher	levels	of	HDmiR-122	and	CDmiR-222	
in	both	perfusate	and	bile.	As	expected,	early	relative	values	of	HDmiR-
122	in	perfusate	showed	a	strong	correlation	with	hepatocyte	injury,	
but	also	with	cholangiocyte	injury	after	6	hours	of	perfusion.	A	simi-
lar	observation,	although	less	pronounced,	was	made	for	CDmiR-222	
in	perfusate.	In	bile,	on	the	other	hand,	HDmiR-122	did	not	correlate	
with	either	hepatocyte	or	cholangiocyte	injury.	CDmiR-222,	however,	
showed	an	even	stronger	correlation	with	both	these	injury	markers	
than	was	observed	for	this	miR	in	perfusate.	 In	terms	of	hepatocyte	
function,	 both	 HDmiR-122	 and	 CDmiR-222	 in	 perfusate	 correlated	
significantly	and	negatively	with	bilirubin	in	bile,	but	lactate	and	cumu-
lative	bile	production	did	not.	The	ratio	of	relative	HDmiR-122/CDmiR-
222	values	after	30	minutes	was	an	early	predictor	of	cumulative	bile	
production	after	6	hours	of	perfusion	and	thereby	a	predictor	of	the	
function	of	non-transplanted	(research)	livers.
Machine	perfusion	is	a	technique	that	is	rapidly	making	its	way	
into	the	clinic	and	can	be	applied	for	various	purposes.	NMP	not	only	
offers	 the	possibility	 to	perform	viability	 testing	of	high-risk	 livers	
in	order	to	select	transplantable	organs,8,13,21-23	but	also	results	in	a	
lower	rate	of	organ	discard	and	lower	levels	of	graft	injury	after	NMP	
compared	to	SCS.24	 In	the	early	detection	of	hepatic	 injury	during	
machine	perfusion,	miRs	in	perfusate	offer	several	advantages.	miRs	
can	withstand	harsh	environmental	conditions,	and	because	the	per-
fusate	circulates	through	the	entire	liver	during	machine	perfusion,	
miR	levels	in	perfusate	provide	a	better	and	non-invasive	represen-
tation of the entire liver compared to miR levels measured in total 
RNA	samples	from	biopsies.11	Furthermore,	miRs	have	been	shown	
to	be	earlier	and	more	sensitive	markers	of	liver	damage	than	more	
conventional	markers	 such	 as	AST	or	ALT,	 and	machine	perfusion	
potentially	 allows	 for	 an	 even	 more	 representative	 and	 dynamic	
evaluation of the liver graft.16,25,26	 In	 addition,	machine	 perfusion	
can	be	used	 for	 the	 resuscitation	of	grafts	but	 fast	and	predictive	
biomarkers,	such	as	miRs,	are	necessary	to	assess	the	effects	of	the	
treatment provided.27-30	Especially	HDmiR-122,	which	is	involved	in	
several	processes	in	the	liver	such	as	lipid	metabolism,	has	the	po-
tential	to	serve	as	a	biomarker	to	monitor	the	effect	of	interventions,	
or as a therapeutic target itself.31
F I G U R E  2  Correlation	and	prediction	of	relative	miRNA	levels	and	miR	ratio	with	Suzuki	injury	score	for	liver	injury.	Relative	level	for	
HDmiR-122	(closed	circles)	and	CDmiR-222	(open	circles)	in	perfusate	at	30	min	correlated	with	Suzuki	injury	scores	prior	to	NMP	(0	h	
NMP,	A).	HDmiR122/CDmiR222	ratios	at	30	min	were	predictive	for	liver	parenchymal	injury	score	after	6	h	of	NMP	(black	squares,	B).	
Spearman's	correlation	coefficient	(r)	and	P-value	are	indicated
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Studies	have	shown	that	HDmiR-122	levels	in	graft	preservation	
fluid	are	higher	in	DCD	grafts	and	in	livers	that	went	on	to	develop	
EAD	 and	NAS.11,12,14	 Higher	HDmiR-122	 levels	 in	 perfusate	were	
also	measured	in	a	porcine	DCD	NMP	model	with	increasing	warm	
ischemia times.11	 Moreover,	 patients	 with	 high	 serum	 AST	 levels	
after	transplantation,	as	well	as	patients	with	acute	liver	failure	and	
chronic	hepatitis	C	infection,	showed	higher	serum	HDmiR-122	lev-
els.32	Our	finding	that	HDmiR-122	levels	 in	perfusate	strongly	and	
positively	 correlated	with	 hepatocellular	 injury	 during	NMP	 is	 en-
tirely	in	line	with	the	currently	available	literature.
In	 addition	 to	 being	 present	 in	 perfusate,	 HDmiR-122	 is	 also	
present	in	bile.	HDmiR-122	was	present	in	bile	of	patients	after	liver	
transplantation	and	levels	decrease	upon	episodes	of	liver	injury.14 
We	confirm	these	findings	in	this	study,	with	higher	levels	of	HDmiR-
122	in	bile	from	livers	with	higher	AST	levels.
In	 our	 study,	 both	 HDmiR-122	 and	 CDmiR-222	 levels	 in	 per-
fusate	were	highest	at	2	hours	of	NMP	and	declined	 thereafter,	 a	
phenomenon	that	has	not	been	described	before.	As	the	perfusion	
solution	was	contained	in	a	closed	circuit,	it	could	be	suggested	that	
HDmiR-122	was	internalized	or	otherwise	metabolized	during	NMP.	
This	phenomenon,	although	less	pronounced,	was	also	observed	for	
CDmiR-222.	This	might	 be	due	 to	 an	 active	 reuptake	process	 and	
decreased	passive	release	of	miRs	by	better	functioning	and	less	in-
jured	grafts.	However,	to	confirm	this	hypothesis	further	research	is	
warranted.33,34	Histological	examination	of	 the	declined	 livers	and	
comparing	these	data	with	HDmiR-122	and	CDmiR-222	revealed	a	
clear	correlation	with	 levels	 in	perfusate	prior,	and,	 to	a	 lesser	ex-
tent,	after	NMP.	This	reduction	in	significance	between	scores	prior	
to	and	after	NMP	also	hints	toward	an	active	resorption	of	miRNA	
while,	at	the	same	time,	injury	that	was	initiated	prior	to	NMP	could	
progress.
Although	not	as	extensively	 studied	as	HDmiR-122,	CDmiR-222	
was	 shown	 to	 be	 abundantly	 expressed	 in	 biliary	 epithelium.14,35 
Elevated	levels	have	been	reported	in	serum	of	patients	with	primary	
F I G U R E  3  Early	relative	HDmiR-122	and	CDmiR-222	levels	in	perfusate	are	predictive	for	hepato-cholangiocellular	injury	at	end	of	
normothermic	machine	perfusion	(NMP).	Relative	level	for	HDmiR-122	(closed	circles)	and	CDmiR-222	(open	circles)	in	perfusate	at	30	min	
correlated	with	hepato-cholangiocellular	injury	markers,	peak	aspartate	aminotransferase	in	perfusate	(A)	and	peak	lactate	dehydrogenase	
in	bile	(B)	at	6	h	of	NMP.	Total	bilirubin	in	bile	at	6	h	NMP	correlated	with	both	HDmiR-122	and	CDmiR-222	at	30	min	(C).	HDmiR-122,	but	
not	CDmiR-222,	at	30	min	was	associated	with	bicarbonate	level	in	bile	at	6	h	NMP	(D).	Spearman's	correlation	coefficient	(r)	and	P-value	are	
indicated
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sclerosing	cholangitis,	in	tissue	of	hepatocellular	carcinoma	and	in	pri-
mary	colorectal	cancer	lesions	with	liver	metastases.36-38	CDmiR-222	
was	also	found	to	be	lower	in	the	preservation	solution	of	grafts	that	
developed	NAS	after	transplantation.12	In	the	present	study,	CDmiR-
222	levels	in	both	perfusate	and	bile	correlated	strongly	and	positively	
with	hepato-cholangiocellular	 injury,	and,	 in	bile,	with	cholangiocyte	
function.	 These	 results	 are	 in	 concordance	 with	 a	 previous	 study	
showing	 that	 higher	CDmiR-222	 levels	 in	 bile	were	 associated	with	
high	hepatocyte	injury	and	poor	hepatocyte	excretory	function.14 The 
finding	that	both	miRs	were	excreted	into	bile	and	strongly	correlated	
with	cellular	excretory	function,	has	been,	as	already	mentioned,	de-
scribed	previously.14
Subsequently,	 we	 observed	 that	 the	 HDmiR-122/CDmiR-222	
ratio	correlated	with	cumulative	bile	production	during	NMP,	with	
significantly	higher	ratios	 in	 livers	with	better	bile	production.	The	
relative	 ratio	 of	 hepatocyte-derived	 and	 cholangiocyte-derived	
miRs	represents	a	relative	degree	of	hepatocellular	 injury	using	an	
internal	stabilization	factor.	Elevated	HDmiR-122/CDmiR-222	ratios	
in	 the	 flushing	 solution	of	 liver	 grafts,	 obtained	prior	 to	 implanta-
tion,	have	previously	been	associated	with	NAS,	EAD,	graft	loss,	and	
DCD	livers	in	humans,11,12	and	was,	in	a	porcine	DCD	model,	directly	
correlated	with	increasing	WIT.11	Future	research	is	necessary	to	de-
termine	whether	miR	 levels	 in	bile	and	perfusate	during	NMP	(but	
also	at	other	temperatures)	can	be	used	to	predict	clinical	outcomes,	
such	as	NAS	or	EAD.
Several	limitations	should	be	considered	in	this	study.	The	liver	
grafts	used	in	this	study	were	not	transplanted	after	preservation;	
hence,	post-transplantation	data	are	not	 available.	Recent	 studies,	
however,	 showed	 that	 the	use	of	NMP	 for	 viability	 assessment	of	
otherwise	 discarded	 grafts	 was	 clinically	 feasible	 13,22,39 and also 
helped to define optimal criteria for the final acceptance of these 
rejected	grafts	once	 their	viability	had	been	 re-assessed.22,40 As a 
consequence,	 the	 clinical	 parameters	 for	 hepato-cholangiocellular	
injury	and	function	were	used	as	mere	viability	markers	to	correlate	
with	 relative	miR	values.15,22,24 Mergental et al proposed compos-
ite	viability	criteria	based	on	analysis	of	12	discarded	human	livers.	
F I G U R E  4  CDmiR-222	levels	in	bile	at	2	h	of	normothermic	machine	perfusion	(NMP)	are	predictive	of	hepato-cholangiocellular	injury	
and	function	at	end	of	NMP.	Relative	CDmiR-222	(open	circles)	values,	but	not	relative	HDmiR-122	values	(closed	circles),	at	2	h	of	NMP	
correlated	with	peak	aspartate	aminotransferase	(AST)	in	perfusate	(A),	and	with	lactate	dehydrogenase	(LDH)	in	bile	(B)	at	6	h	of	NMP	
(6	h	NMP).	In	the	case	of	bicarbonate	in	bile	at	6	h	NMP,	also	only	CDmiR-222,	and	not	HDmiR-122,	at	2	h	showed	a	strong,	but	negative,	
correlation	(C),	while	both	miRs	were	predictive	of	the	bile/perfusate	glucose	ratio	at	6	h	(D).	Spearman's	correlation	coefficient	(r)	and	P-
value are indicated
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Multilevel	 statistical	 analysis	 showed	 that	 lactate	 clearance	 strati-
fied	his	cohort	 in	2	distinct	groups	with	pH	and	bile	production	as	
discriminative parameters.22	 It	 should,	 however,	 be	 noted	 that	 in	
studies	where	 livers	were	 transplanted	 after	NMP,	 these	 parame-
ters	 tend	to	vary	extensively	and	are	not	predictive	 for	 transplant	
outcome	after	NMP	alone.8,21 As lactate levels for the transplanted 
livers	 in	 the	 studies	 by	Watson	 and	 by	Mergental	 dropped	 below	
2.5	mmol/L	in	4	out	of	6	grafts	and	42	out	of	47	grafts	after	2	hours	
of	NMP,	respectively,	in	our	cohort	only	one	reached	this	level	in	this	
period.	No	correlation	between	this	parameter	and	relative	miRNA	
values	in	perfusate	at	30	minutes	and	bile	after	2	hours	in	our	cohort	
was	 observed,	 nor	with	 the	 other	 viability	 criteria	 components.	 It	
should	be	noted,	however	that,	as	far	as	lactate	is	concerned,	2	hours	
of	NMP	are	sufficient	to	assess	viability.	For	pH,	to	determine	sta-
bility,	 longer	periods	of	NMP	are	 required	as	 the	 first	2	hours	are	
already	needed	 to	 reach	a	plateau.	At	present,	 a	6-hour	period	of	
NMP,	either	with	or	without	additional	perfusion	treatments,	is	still	
considered	 the	 standard.	 Another	 limitation	 is	 the	 relatively	 small	
number	of	liver	grafts	included	in	this	study	due	to	a	minimal	avail-
ability	of	research	livers.	To	avoid	further	stratification	and	reduced	
numbers,	both	DCD	and	DBD	 livers	were	 included.	Despite	 these	
small	numbers	and	graft	type	heterogeneity,	there	were	still	signif-
icant	differences	observed	 in	miR	detection	 in	perfusate	 and	bile,	
which	supports	the	utility	of	relative	miR	values	to	serve	as	poten-
tial,	 dynamic,	 biomarkers.	 Lastly,	 the	measurement	of	miRs	 is	 cur-
rently	a	time-consuming	process,	as	it	takes	4-5	hours	to	complete	
the	analysis,	 although	 techniques	are	under	development	 to	make	
clinical	applications	possible.41	Nonetheless,	the	predictive	proper-
ties	of	these	miRs	might	aid	in	the	detection	of	transplantable	livers	
or the effects of the efforts to improve the graft during machine per-
fusion.	Therefore,	the	dynamics	of	miRs	during	perfusion	in	a	closed	
circuit	shown	 in	this	study	can	give	new	insights	 in	the	kinetics	of	
miRs	as	biomarkers	in	general.
In	conclusion,	this	study	shows	that	HDmiR-122	and	CDmiR-222	
levels	in	bile	and	perfusate,	already	at	early	stages	of	NMP,	are	pre-
dictive	of	late	classic	markers	of	injury	and	function.	Furthermore,	the	
relative	ratio	of	hepatocyte-derived	and	cholangiocyte-derived	miRs	
is	predictive	of	the	cumulative	bile	production	during	perfusion.	It	will	
be	of	utmost	importance	to	determine	whether	miR	levels	maintain	
a	steady-state	profile	or	whether	they	will	change	during	pre-implant	
interventions	and	what	the	level	profiles	will	be	for	(normothermic)	
machine	perfused	liver	grafts	once	they	are	used	for	transplantation.
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